Politics
Briefing: A new drug could be the beginning of the end for sleeping sickness
Strategic angle: The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job.
editorial-staff
1 min read
Updated 26 days ago
Recent advancements in drug development could significantly impact the fight against sleeping sickness, a disease caused by the Trypanosoma parasite.
The global health community has set a target to eliminate this disease by 2030, and this new drug may play a crucial role in achieving that objective.
As implementation strategies are considered, the capacity for widespread distribution and integration into existing health systems will be critical for success.